UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...

PRISM BioLab, Co. Ltd. ("PRISM BioLab"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced ...

M ass firings hit U.S. health agencies over the past week, but disruptions to the nation’s medical research system have been ...

March 31 (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the ...

New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery Center Photo 1 Left to Right: Ethan Grimes, BS, and Paul Morgan, MD, conduct ...

This eBook explores the latest advancements in drug discovery, from AI-driven precision medicine to the promise and risks of new weight loss drugs.